SAVA - Cassava Shares Are Down Over 30%: Here's Why | Benzinga
Cassava Sciences, Inc. (NASDAQ:SAVA) shares are trading significantly lower on Friday following the indictment of Hoau-Yan Wang, a tenured medical professor and advisor to the company, by a federal grand jury.
What’s Going On: Wang has been accused of fabricating scientific data in grant applications to the U.S. National Institutes of Health (NIH), resulting in the misappropriation of approximately $16 million in federal funds intended ...